Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders

Brieana M. Rowles, Robert L Findling

Research output: Contribution to journalArticle

Abstract

Developmental disorders such as subaverage intelligence, pervasive developmental disorders, and genetic syndromes are frequently associated with comorbid attention-deficit/hyperactivity disorder (ADHD) or ADHD-like symptoms. While there are not pharmacological cures for these developmental disorders, coinciding ADHD and ADHD-like symptoms that contribute to difficulties in psychosocial functioning are frequently able to be addressed by pharmacotherapy. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from developmental disorders and comorbid ADHD/ADHD-like symptoms.

Original languageEnglish (US)
Pages (from-to)273-282
Number of pages10
JournalDevelopmental Disabilities Research Reviews
Volume16
Issue number3
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Attention Deficit Disorder with Hyperactivity
Drug Therapy
Therapeutics
Pharmacology
Inborn Genetic Diseases
Intelligence

Keywords

  • Attention-deficit/hyperactivity disorder
  • Developmental disorder
  • Subaverage intelligence
  • Treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

@article{c94214575c3c44cf8ad0ad23495b47d6,
title = "Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders",
abstract = "Developmental disorders such as subaverage intelligence, pervasive developmental disorders, and genetic syndromes are frequently associated with comorbid attention-deficit/hyperactivity disorder (ADHD) or ADHD-like symptoms. While there are not pharmacological cures for these developmental disorders, coinciding ADHD and ADHD-like symptoms that contribute to difficulties in psychosocial functioning are frequently able to be addressed by pharmacotherapy. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from developmental disorders and comorbid ADHD/ADHD-like symptoms.",
keywords = "Attention-deficit/hyperactivity disorder, Developmental disorder, Subaverage intelligence, Treatment",
author = "Rowles, {Brieana M.} and Findling, {Robert L}",
year = "2010",
doi = "10.1002/ddrr.120",
language = "English (US)",
volume = "16",
pages = "273--282",
journal = "Mental Retardation and Developmental Disabilities Research Reviews",
issn = "1080-4013",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders

AU - Rowles, Brieana M.

AU - Findling, Robert L

PY - 2010

Y1 - 2010

N2 - Developmental disorders such as subaverage intelligence, pervasive developmental disorders, and genetic syndromes are frequently associated with comorbid attention-deficit/hyperactivity disorder (ADHD) or ADHD-like symptoms. While there are not pharmacological cures for these developmental disorders, coinciding ADHD and ADHD-like symptoms that contribute to difficulties in psychosocial functioning are frequently able to be addressed by pharmacotherapy. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from developmental disorders and comorbid ADHD/ADHD-like symptoms.

AB - Developmental disorders such as subaverage intelligence, pervasive developmental disorders, and genetic syndromes are frequently associated with comorbid attention-deficit/hyperactivity disorder (ADHD) or ADHD-like symptoms. While there are not pharmacological cures for these developmental disorders, coinciding ADHD and ADHD-like symptoms that contribute to difficulties in psychosocial functioning are frequently able to be addressed by pharmacotherapy. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from developmental disorders and comorbid ADHD/ADHD-like symptoms.

KW - Attention-deficit/hyperactivity disorder

KW - Developmental disorder

KW - Subaverage intelligence

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=79952788922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952788922&partnerID=8YFLogxK

U2 - 10.1002/ddrr.120

DO - 10.1002/ddrr.120

M3 - Article

VL - 16

SP - 273

EP - 282

JO - Mental Retardation and Developmental Disabilities Research Reviews

JF - Mental Retardation and Developmental Disabilities Research Reviews

SN - 1080-4013

IS - 3

ER -